Administration of 24-h Intravenous Infusions of Trabectedin in Ambulatory Patients with Mesenchymal Tumors via Disposable Elastomeric Pumps: An Effective and Patient-Friendly Palliative Treatment Option

Patrick Schöffski(KU Leuven), Marguerite Stas(Morpho (United States)), Pascal Wolter(KU Leuven), Paul M. Clément(Universitair Ziekenhuis Leuven), Herlinde Dumez, Ivo De Wever, Hans Wildiers(KU Leuven), Ignace Samson, Linda Cerbone(Carlo Forlanini Hospital)
Onkologie
January 1, 2012
10.1159/000335879
Cited by 18

Related Papers

Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
|New England Journal of Medicine|2014|2.7k
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
|The Lancet|2012|1.4k
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
|The Lancet Oncology|2014|1.2k
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994